These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10986119)

  • 1. The bicyclomycin sensitivities of 38 bicyclomycin-resistant mutants of transcription termination protein rho and the location of their mutations support a structural model of rho based on the F(1) ATPase.
    Moyse KA; Knight JS; Richardson JP
    J Mol Biol; 2000 Sep; 302(3):565-79. PubMed ID: 10986119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic characterization of a comprehensive set of bicyclomycin-resistant mutants.
    Moyse KA; Knight JS; Richardson JP
    Biochim Biophys Acta; 2001 Sep; 1520(3):223-33. PubMed ID: 11566358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription termination factor rho: the site of bicyclomycin inhibition in Escherichia coli.
    Zwiefka A; Kohn H; Widger WR
    Biochemistry; 1993 Apr; 32(14):3564-70. PubMed ID: 8466900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho transcription factor: symmetry and binding of bicyclomycin.
    Vincent F; Openshaw M; Trautwein M; Gaskell SJ; Kohn H; Widger WR
    Biochemistry; 2000 Aug; 39(31):9077-83. PubMed ID: 10924100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis for the mode of action of bicyclomycin.
    Kohn H; Widger W
    Curr Drug Targets Infect Disord; 2005 Sep; 5(3):273-95. PubMed ID: 16181146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional dissections of transcription termination factor rho by random mutagenesis.
    Miwa Y; Horiguchi T; Shigesada K
    J Mol Biol; 1995 Dec; 254(5):815-37. PubMed ID: 7500353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bicyclomycin and dihydrobicyclomycin inhibition kinetics of Escherichia coli rho-dependent transcription termination factor ATPase activity.
    Park HG; Zhang X; Moon HS; Zwiefka A; Cox K; Gaskell SJ; Widger WR; Kohn H
    Arch Biochem Biophys; 1995 Nov; 323(2):447-54. PubMed ID: 7487110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the bicyclomycin binding domain through biochemical analysis of antibiotic-resistant rho proteins.
    Magyar A; Zhang X; Abdi F; Kohn H; Widger WR
    J Biol Chem; 1999 Mar; 274(11):7316-24. PubMed ID: 10066795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycin.
    Skordalakes E; Brogan AP; Park BS; Kohn H; Berger JM
    Structure; 2005 Jan; 13(1):99-109. PubMed ID: 15642265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the location of bicyclomycin binding to the Escherichia coli transcription termination factor Rho.
    Riba I; Gaskell SJ; Cho H; Widger WR; Kohn H
    J Biol Chem; 1998 Dec; 273(51):34033-41. PubMed ID: 9852059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antibiotic bicyclomycin affects the secondary RNA binding site of Escherichia coli transcription termination factor Rho.
    Magyar A; Zhang X; Kohn H; Widger WR
    J Biol Chem; 1996 Oct; 271(41):25369-74. PubMed ID: 8810302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Screen for
    Hu K; Artsimovitch I
    mBio; 2017 May; 8(3):. PubMed ID: 28559482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bicyclomycin sensitivity and resistance affect Rho factor-mediated transcription termination in the tna operon of Escherichia coli.
    Yanofsky C; Horn V
    J Bacteriol; 1995 Aug; 177(15):4451-6. PubMed ID: 7543478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a technique to determine bicyclomycin-rho binding and stoichiometry by isothermal titration calorimetry and mass spectrometry.
    Brogan AP; Widger WR; Bensadek D; Riba-Garcia I; Gaskell SJ; Kohn H
    J Am Chem Soc; 2005 Mar; 127(8):2741-51. PubMed ID: 15725032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bicyclomycin on RNA- and ATP-binding activities of transcription termination factor Rho.
    Carrano L; Bucci C; De Pascalis R; Lavitola A; Manna F; Corti E; Bruni CB; Alifano P
    Antimicrob Agents Chemother; 1998 Mar; 42(3):571-8. PubMed ID: 9517934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP binding to Rho transcription termination factor. Mutant F355W ATP-induced fluorescence quenching reveals dynamic ATP binding.
    Xu Y; Johnson J; Kohn H; Widger WR
    J Biol Chem; 2003 Apr; 278(16):13719-27. PubMed ID: 12551938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis-based evidence for an asymmetric configuration of the ring-shaped transcription termination factor Rho.
    Rabhi M; Gocheva V; Jacquinot F; Lee A; Margeat E; Boudvillain M
    J Mol Biol; 2011 Jan; 405(2):497-518. PubMed ID: 21059356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicyclomycin fluorescent probes: synthesis and biochemical, biophysical, and biological properties.
    Brogan AP; Widger WR; Kohn H
    J Org Chem; 2003 Jul; 68(14):5575-87. PubMed ID: 12839449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription termination defective mutants of Rho: role of different functions of Rho in releasing RNA from the elongation complex.
    Chalissery J; Banerjee S; Bandey I; Sen R
    J Mol Biol; 2007 Aug; 371(4):855-72. PubMed ID: 17599352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5a-formylbicyclomycin: studies on the bicyclomycin-Rho interaction.
    Vincent F; Widger WR; Openshaw M; Gaskell SJ; Kohn H
    Biochemistry; 2000 Aug; 39(31):9067-76. PubMed ID: 10924099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.